The tweet was deleted by the author.
But we saved everything 🙂.
CVRx will host a webinar on Thursday, March 12 to review late-breaking data from THT2026.
The event will feature Chief Medical Officer Dr. Philip Adamson moderating a roundtable with Dr. Farooq Sheikh and Dr. Hector Lozano to discuss the latest clinical findings and share updates on ongoing studies. The focus on new data underscores the continued research momentum in advanced cardiovascular treatment.
The latest focus on clinical breakthroughs builds on CVRx’s earlier advancements, including its collaboration with Orlando Health South Lake Hospital for the first Barostim implant to enhance heart failure care. Continued progress is further reflected in the company’s milestone of reaching the 101st Barostim implant, underscoring its expanding impact in cardiovascular treatment.